BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 19638646)

  • 1. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2548. PubMed ID: 19638647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
    Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
    BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
    Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
    BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2549. PubMed ID: 19638648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
    Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
    Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
    Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
    Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities.
    Kelly RS; Walker P; Kitchener H; Moss SM
    BJOG; 2012 Jan; 119(1):20-5. PubMed ID: 21624034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of women with mild and moderate cervical dyskaryosis.
    Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
    BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.
    Fielding S; Rothnie K; Gray NM; Little J; Cruickshank ME; Neal K; Walker LG; Whynes D; Cotton SC; Sharp L;
    Psychooncology; 2017 Apr; 26(4):476-483. PubMed ID: 27297097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.
    Sahlgren H; Elfström KM; Lamin H; Carlsten-Thor A; Eklund C; Dillner J; Elfgren K
    Am J Obstet Gynecol; 2020 Mar; 222(3):253.e1-253.e8. PubMed ID: 31585095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.
    Elfgren K; Elfström KM; Naucler P; Arnheim-Dahlström L; Dillner J
    Am J Obstet Gynecol; 2017 Mar; 216(3):264.e1-264.e7. PubMed ID: 27825977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence supporting see-and-treat management of cervical intraepithelial neoplasia: a systematic review and meta-analysis.
    Ebisch RM; Rovers MM; Bosgraaf RP; van der Pluijm-Schouten HW; Melchers WJ; van den Akker PA; Massuger LF; Bekkers RL
    BJOG; 2016 Jan; 123(1):59-66. PubMed ID: 26177672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.
    Kyrgiou M; Kalliala I; Mitra A; Ng KY; Raglan O; Fotopoulou C; Martin-Hirsch P; Paraskevaidis E; Arbyn M
    Int J Cancer; 2017 Jan; 140(1):216-223. PubMed ID: 27603593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA).
    Sharp L; Cotton S; Carsin AE; Gray N; Thornton A; Cruickshank M; Little J;
    Psychooncology; 2013 Feb; 22(2):368-80. PubMed ID: 22162138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.